I-BRD9,
1714146-59-4,
GSK602,
CHEMBL3769507,
N'-[1,1-Bis(Oxidanylidene)thian-4-Yl]-5-Ethyl-4-Oxidanylidene-7-[3-(Trifluoromethyl)phenyl]thieno[3,2-C]pyridine-2-Carboximidamide,
compound 45 [PMID 25856009],
i-brd9-gsk602,
GTPL8397,
I-BRD9(GSK602),
I-BRD9 (GSK602),
BCP17832,
EX-A1639,
BDBM50147620,
AKOS027423696,
ZINC231374665,
CS-5587,
I-BRD9, >=98% (HPLC),
SB19813,
AK475253,
AS-16366,
HY-18975,
N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-5-ethyl-4-oxo-7-(3-(trifluoromethyl)phenyl)-4,5-dihydrothieno[3,2-c]pyridine-2-carboximidamide,
S7835,
J3.601.426A,
5-Ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide,
H1B,
N-(1,1-dioxo-1lambda6-thian-4-yl)-5-ethyl-4-oxo-7-[3-(trifluoromethyl)phenyl]-4H,5H-thieno[3,2-c]pyridine-2-carboximidamide,
N-[(Tetrahydro-2H-thiopyran 1,1-dioxide)-4-yl]-4-oxo-5-ethyl-7-[3-(trifluoromethyl)phenyl]-4,5-dihydrothieno[3,2-c]pyridine-2-carboxamidine,
D0N5BI,
A15872,